Search This Blog

Tuesday, August 6, 2019

Flexion Therapeutics EPS beats by $0.09, beats on revenue

Flexion Therapeutics (NASDAQ:FLXN): Q2 GAAP EPS of -$0.96 beats by $0.09.
Revenue of $16.95M (+347.2% Y/Y) beats by $1.99M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)